|
Real-time Estimate
Cboe BZX
12:47:51 2026-10-01 EDT
|
5-day change | 1st Jan Change | ||
| 4.485 USD | -3.96% |
|
-7.10% | +56.14% |
| 09-20 | Oramed Pharmaceuticals Inc.(NasdaqCM:ORMP) added to S&P Global BMI Index | CI |
| 08-31 | Lifeward Names Josh Hexter as Interim CEO and Rami Aviram as CFO | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -3.96% | -7.10% | -8.25% | -3.47% | +56.14% | +74.51% | +73.15% | -78.74% | -38.79% | 194M | |
| +4.16% | -0.36% | +8.11% | +34.40% | +84.62% | +49.37% | +94.17% | +9.52% | - | 74.46B | |
| -0.61% | +0.81% | -5.03% | +6.05% | +17.41% | +27.25% | +80.21% | +220.61% | +5,462.46% | 60.14B | |
| -2.54% | -1.65% | -2.98% | -0.36% | +4.24% | +4.86% | +33.32% | -19.36% | +200.59% | 48.15B | |
| -2.14% | -3.90% | +2.30% | +30.07% | +17.25% | +29.69% | +36.32% | +9.42% | +229.55% | 44.25B | |
| +1.91% | +4.85% | -0.15% | +11.75% | +163.08% | +356.92% | +700.71% | +619.59% | - | 43.99B | |
| -1.24% | +0.51% | +0.88% | +24.45% | +19.09% | +7.95% | +102.70% | +1.43% | +1,067.16% | 41.61B | |
| +3.32% | +3.49% | -2.81% | +5.94% | +6.51% | +11.18% | +51.23% | -13.94% | +145.56% | 29.97B | |
| +4.77% | +6.16% | +14.76% | +61.99% | +78.28% | +36.77% | +22.78% | -55.69% | - | 29.31B | |
| -3.15% | -8.55% | -8.52% | +3.89% | -36.13% | -24.52% | +338.16% | +305.99% | +663.46% | 24.93B | |
| -0.86% | -1.83% | -4.42% | +3.75% | +2.35% | -4.67% | -13.58% | -61.76% | - | 24.69B | |
| -1.28% | +1.98% | +7.73% | +28.50% | +14.11% | +16.44% | -5.36% | -16.07% | +102.54% | 21.27B | |
| -3.15% | -2.01% | +4.27% | +11.87% | +8.27% | +11.81% | +150.70% | +210.85% | +1,891.84% | 17.42B | |
| -3.70% | -0.43% | -16.13% | -3.15% | +176.14% | +152.01% | +328.65% | +1,525.59% | +638.60% | 15.8B | |
| -0.61% | -4.09% | +4.16% | +8.88% | +19.46% | +18.20% | +42.41% | -29.60% | +81.10% | 14.79B | |
| -0.21% | -1.17% | -12.40% | -14.86% | - | - | - | - | - | 14.96B | |
| -5.07% | -5.11% | +25.33% | +26.69% | +32.16% | -11.31% | - | - | - | 14.78B | |
| -0.23% | +0.66% | +2.53% | +8.10% | +33.08% | +41.58% | +162.51% | +170.80% | +358.57% | 14.47B | |
| +2.96% | +0.83% | -2.05% | +11.65% | +24.17% | -5.25% | +535.77% | - | - | 14.83B | |
| -2.49% | -1.81% | +2.40% | +26.20% | +44.93% | +69.59% | +49.50% | -30.62% | +245.49% | 14.08B | |
| Average | -0.68% | +1.86% | +0.49% | +14.12% | +40.27% | +45.39% | +154.63% | +162.82% | +849.86% | 28.21B | |
| Weighted average by Cap. | +0.03% | +1.84% | +1.05% | +17.16% | +42.62% | +51.28% | +149.31% | +142.15% | +1,350.39% |
- Stock Market
- Stocks
- ORMP Stock
- Sector Oramed Pharmaceuticals Inc.
Select your edition
All financial news and data tailored to specific country editions
